Breaking News, Promotions & Moves

Aileron Therapeutics Names President & CEO

Manuel Aivado, MD, PhD has over 20 years experience, and has served as Aileron’s SVP, CMO, and CSO since 2012

Aileron Therapeutics announced that Manuel Aivado, MD, PhD, has been named president and chief executive officer and elected to its Board of Directors.    Since 2012, Dr. Aivado has served as Aileron’s senior vice president and chief medical and scientific officer.  He succeeds John P. Longenecker, PhD, who was appointed interim chief executive officer on May 15, 2018.  “We are very pleased to announce this well-deserved promotion for Dr. Aivado,” said Aileron Chairman Jeff ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters